When should a higher dose of epinephrine be used, such as in refractory anaphylaxis, prolonged cardiac arrest, severe bronchospasm or hypotension unresponsive to standard therapy, or in patients weighing more than 100 kg?

Higher-Dose Epinephrine: When to Use It

Higher doses of epinephrine should NOT be used routinely in standard cardiac arrest, as they do not improve survival or neurological outcomes, but may be considered specifically for β-blocker or calcium-channel blocker overdose. 1

Standard Cardiac Arrest: Avoid High-Dose Epinephrine

The American Heart Association assigns a Class III (No Benefit) recommendation to high-dose epinephrine (0.1–0.2 mg/kg) for routine cardiac arrest. 1 The evidence is clear:

• Randomized trials demonstrate no improvement in survival to hospital discharge compared with standard 1 mg dosing. 1
• Neurological outcomes at discharge are not improved with higher doses. 1
• Although high-dose epinephrine may temporarily increase return of spontaneous circulation (ROSC), this does not translate into meaningful survival benefit. 1
• Standard-dose epinephrine (1 mg IV/IO every 3–5 minutes) remains the evidence-based approach for all routine cardiac arrest situations. 1

Post-Arrest Harm

Excessive epinephrine dosing may exacerbate myocardial dysfunction through heightened β-adrenergic stimulation, increasing myocardial oxygen demand and reducing sub-endocardial perfusion. 1

---

Toxicologic Emergencies: The Only Reasonable Indication

The 2015 AHA Guidelines identify β-blocker overdose and calcium-channel blocker overdose as the only scenarios where high-dose epinephrine may be considered reasonable. 1

• In these poisoning contexts, the usual 1 mg bolus may be insufficient to overcome receptor blockade or calcium-channel antagonism. 1
• Higher doses are needed to compete with the toxin at receptor sites and restore hemodynamic function. 1

---

Anaphylaxis: Repeat Standard Doses, Not Higher Single Doses

For anaphylaxis, the maximum single dose of epinephrine for adults is capped at 0.5 mg, despite body weight, as higher doses increase cardiac adverse effects without improving outcomes. 2

Repeat Dosing Protocol

• There is no maximum number of intramuscular epinephrine 1:1000 doses for anaphylaxis—repeat every 5 minutes as needed until symptoms resolve. 2
• Most patients require 1–2 doses, but approximately 10–20% require more than one dose before symptom recovery. 2
• The number of doses should be determined by clinical response rather than an arbitrary maximum. 2

When to Escalate Beyond IM Epinephrine

• If a patient fails to respond to multiple IM doses, consider transitioning to IV epinephrine infusion (starting at 1–4 mcg/min, titrating up to maximum 10 mcg/min), which requires continuous hemodynamic monitoring. 2
• Delaying epinephrine administration can be fatal—fatalities are associated with delayed epinephrine, not with giving multiple doses. 2

Critical Safety Point

There is no absolute contraindication to epinephrine use in anaphylaxis, even in elderly patients or those with cardiac disease, as the risk of death from untreated anaphylaxis far exceeds the risk of epinephrine-related adverse effects. 2

---

Physiologic Titration: Limited Evidence

High-dose epinephrine can be titrated to real-time physiologic parameters (e.g., arterial pressure during CPR), but this approach lacks robust supporting evidence. 1

---

Weight-Based Dosing: Not Recommended

Body weight does not justify higher single doses of epinephrine. The maximum single dose remains 0.5 mg for adults regardless of weight, as higher doses increase cardiac adverse effects without improving outcomes. 2 For patients weighing more than 100 kg, repeat standard doses every 5 minutes as needed rather than increasing the single dose. 2

---

Common Pitfalls to Avoid

• Escalating to high-dose epinephrine in standard cardiac arrest does not improve survival and may worsen neurological outcomes; it should be avoided. 1
• Confusing anaphylaxis dosing with cardiac arrest dosing can lead to iatrogenic overdose and potentially lethal cardiac complications. 3
• Stopping at one dose prematurely in anaphylaxis can lead to persistent or progressing symptoms—if symptoms persist or progress, continue dosing every 5 minutes. 2
• Confusing concentrations: Always use 1:1000 (1 mg/mL) for IM injection; 1:10,000 is reserved for IV use only. 2